You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 89 No. 6, June 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (159)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Industrially Acquired Porphyria

JACOB BLEIBERG, MD; MARVEN WALLEN, MD; ROGER BRODKIN, MD; IRVIN L. APPLEBAUM, MD

Arch Dermatol. 1964;89(6):793-797.


Abstract

Twenty-nine patients working in a chemical factory engaged in the manufacture of 2,4-dichlorophenol (2,4-D) and 2,4,5-trichlorophenol (2,4,5-T) exhibiting features of chloracne were studied for the presence of porphyria cutanea tarda. In II cases urinary uroporphyrins were elevated.

Two of these patients who showed evidence of acquired porphyria with chloracne were hospitalized. The features of chloracne as well as the clinical and laboratory features of acquired porphyria have been discussed. There appeared to be an etiologic but not quantitative relationship between the chloracne in workers engaged in the manufacture of 2,4-D and 2,4,5-T and porphyria cutanea tarda of the acquired type. It is our feeling that either the finished chemicals or some intermediate are responsible for both diseases.



Author Affiliations

NEWARK, NJ

From the Departments of Dermatology and Medicine, Newark Beth Israel Hospital.

Chief of Dermatology, Newark Beth Israel Hospital (Dr. Bleiberg); Senior Resident Physician in Medicine, Newark Beth Israel Hospital (Dr. Wallen); Assistant in Dermatology, Newark Beth Israel Hospital (Dr. Brodkin); Director of Medical Education and Consultant in Medicine, Newark Beth Israel Hospital (Dr. Applebaum).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Comprehensive, Integrated Review and Evaluation of the Scientific Evidence Relating to the Safety of the Herbicide 2,4-D
Munro et al.
International Journal of Toxicology 1992;11:559-664.
ABSTRACT  

Health Status of Air Force Veterans Occupationally Exposed to Herbicides in Vietnam: I. Physical Health
Wolfe et al.
JAMA 1990;264:1824-1831.
ABSTRACT  

Polychlorinated Dibenzo-p-dioxins and Polychlorinated Dibenzofurans: The Risks to Human Health. A Review
Skene et al.
Hum Exp Toxicol 1989;8:173-203.
ABSTRACT  

Human Health Effects of 2,4,5-T and Its Toxic Contaminants
Suskind and Hertzberg
JAMA 1984;251:2372-2380.
ABSTRACT  

Dioxin in soil: bioavailability after ingestion by rats and guinea pigs
McConnell et al.
Science 1984;223:1077-1079.
ABSTRACT  

Epidemiology of Hexachlorobenzene-Induced Porphyria in Turkey: Clinical and Laboratory Follow-up After 25 Years
Peters et al.
Arch Neurol 1982;39:744-749.
ABSTRACT  

Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin
Sweeny et al.
Science 1979;204:332-335.
ABSTRACT  

Chloracne From Manufacture of a New Herbicide
Taylor et al.
Arch Dermatol 1977;113:616-619.
ABSTRACT  

Porphyria Cutanea Tarda Associated With Disinfectant Misuse
Lynch et al.
Arch Intern Med 1975;135:549-552.
ABSTRACT  

2,3,7,8-Tetrachlorodibenzo-p-dioxin: A Potent Inducer of dgr-Aminolevulinic Acid Synthetase
Poland and Glover
Science 1973;179:476-477.
ABSTRACT  

Porphyria Cutanea Tarda and Estrogens
Vail
JAMA 1967;201:671-674.
ABSTRACT  

Precipitation of Acute Intermittent Porphyria by Griseofulvin Therapy
Berman and Franklin
JAMA 1965;192:1005-1007.
ABSTRACT  

RE: "INDUSTRIALLY ACQUIRED PORPHYRIA"
Pass and Larsen
Arch Dermatol 1965;91:93-93.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.